‘Malta will play an important role in the global cannabis supply chain’ – Materia’s Nick Pateras

Materia Malta, a subsidiary of medical cannabis producer and distributor Materia, has just completed its first export of commercial medical cannabis from its EU GMP manufacturing site.

This milestone represents the launch of Materia’s own brand and manufactured products into Germany – Europe’s largest medical cannabis market.

Materia’s German distribution subsidiary, Materia Deutschland GmbH, which took delivery of the shipment, has commenced sales to pharmacies with a number of pre-orders already received.

“Our products are already helping patients in Malta improve their quality of life, and now we can support the needs of patients in Germany too,” Nick Pateras, Materia Managing Director for Europe said.

“We believe Malta will play an important role in the global cannabis supply chain, as it has done with the broader pharmaceuticals sector for decades. We are proud to be the company establishing new frontiers for Malta and Europe’s cannabis industries,” he continued.

The company noted that it became ‘the first’ Malta-based manufacturer of medical cannabis to export product for commercial sale in another country, with previous exports having only been approved for research and development or lab testing purposes.